Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.
about
A Perspective of Immunotherapy for Prostate CancerCancer immunoprevention.Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate Cancer.Dendritic cell therapy in melanoma.Malignancies in HIV-Infected and AIDS Patients.Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.Trial watch: DNA-based vaccines for oncological indications
P2860
Q26741277-17296057-C21C-4D10-8F65-71BC266B4917Q36723234-E86C9797-4B04-432E-9355-CE6986135ABFQ39093352-E1CF11CD-521F-4107-ADF4-0CC56A51BC1EQ39189908-45CABA62-B5D8-488F-9168-A2422C1280DAQ42755227-30B97D19-026D-4FF9-9DF8-B98E4B41C540Q43923587-FBE8060C-A024-41AE-99D0-2B43B7B692CDQ47886730-6F7F8464-6345-43E2-9CD7-861114F34D79Q53159624-FD305597-F4DC-436D-A414-33F7C499F526Q56893452-D1D54BA6-EFF6-4796-BCFA-A963E7C45E8B
P2860
Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.
@en
type
label
Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.
@en
prefLabel
Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.
@en
P2093
P2860
P1476
Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.
@en
P2093
Eric J Small
Lawrence Fong
Xiao X Wei
P2860
P304
P356
10.1586/14760584.2015.1099437
P577
2015-10-21T00:00:00Z